[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"currency-rates":3,"$fyk2oeqxpb7bd":8,"compound-J-2827-9":171,"verified-suppliers-J-2827-9":416},{"rates":4,"source":7},{"USD":5,"CNY":6},1,6.691314,"live",{"rows":9,"total":170,"current":5,"size":145},[10,33,45,60,74,85,96,113,123,135,146,158],{"slug":11,"cid":12,"imgSvg":13,"name":14,"nameZh":15,"cas":16,"formula":17,"iupac":14,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":22,"offersCount":24,"supplierCount":25,"bestOffer":26},"843627791009189888","J-1971488-8","\u002Fimages\u002Fchem_structures_svg\u002F399\u002F65845-61-6.svg","N-Methylcyclohexanamine hydrochloride","N-甲基环己胺盐酸盐","65845-61-6","C7H16ClN","acids","有机酸","Organic Acids","",[23],"In Stock",4,2,{"unitPrice":27,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},2.64,"500g","CNY","China","CN","in-stock",{"slug":34,"cid":35,"imgSvg":36,"name":37,"nameZh":38,"cas":39,"formula":40,"iupac":37,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":41,"offersCount":24,"supplierCount":5,"bestOffer":42},"785882541994283008","J-1323843-4","\u002Fimages\u002Fchem_structures_svg\u002F104\u002F67627-18-3.svg","Potassium indigotrisulfonate","靛蓝三磺酸钾","67627-18-3","C16H7K3N2O11S3",[23],{"unitPrice":43,"pack":44,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},180,"5g",{"slug":46,"cid":47,"imgSvg":48,"name":49,"nameZh":50,"cas":51,"formula":52,"iupac":49,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":56,"offersCount":57,"supplierCount":25,"bestOffer":58},"785889752443260928","J-28559-9","\u002Fimages\u002Fchem_structures_svg\u002F292\u002F15060-55-6.svg","Ammonium tetrathiomolybdate","四硫钼酸铵","15060-55-6","H8MoN2S4","inorganic","无机化合物","Inorganic Chemicals",[23],7,{"unitPrice":59,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},24,{"slug":61,"cid":62,"imgSvg":63,"name":64,"nameZh":65,"cas":66,"formula":67,"iupac":64,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":68,"offersCount":69,"supplierCount":25,"bestOffer":70},"855452191530422272","J-1994428-7","\u002Fimages\u002Fchem_structures_svg\u002F500\u002F16350-96-2.svg","N-benzylcyclohexanamine.hydrochloride","N-苄基环己胺盐酸盐","16350-96-2","C13H20ClN",[23],5,{"unitPrice":71,"pack":72,"currency":29,"origin":73,"originFlag":31,"moq":21,"stock":32},6,"1000g","中国",{"slug":75,"cid":76,"imgSvg":77,"name":78,"nameZh":79,"cas":80,"formula":81,"iupac":78,"category":18,"categoryName":19,"categoryEnName":20,"industry":21,"tags":82,"offersCount":25,"supplierCount":25,"bestOffer":83},"785871840001134592","J-982001-0","\u002Fimages\u002Fchem_structures_svg\u002F001\u002F10517-44-9.svg","1,3-Diaminopropane dihydrochloride","1,3-二氨基丙烷二盐酸盐","10517-44-9","C3H12Cl2N2",[23],{"unitPrice":84,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},3.78,{"slug":86,"cid":87,"imgSvg":88,"name":89,"nameZh":90,"cas":91,"formula":92,"iupac":89,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":93,"offersCount":57,"supplierCount":94,"bestOffer":95},"785880365658017792","J-14975-6","\u002Fimages\u002Fchem_structures_svg\u002F262\u002F12003-67-7.svg","Lithium aluminate","氧化铝锂","12003-67-7","AlHLiO2",[23],3,{"unitPrice":94,"pack":28,"currency":29,"origin":73,"originFlag":31,"moq":21,"stock":32},{"slug":97,"cid":98,"imgSvg":99,"name":100,"nameZh":101,"cas":102,"formula":103,"iupac":100,"category":104,"categoryName":105,"categoryEnName":106,"industry":21,"tags":107,"offersCount":108,"supplierCount":108,"bestOffer":109},"785871830249377792","J-6931-9","\u002Fimages\u002Fchem_structures_svg\u002F456\u002F58068-80-7.svg","1-Octanoylbenzotriazole","N-辛酰苯并三唑","58068-80-7","C14H19N3O","aromatics","芳香烃","Aromatic Hydrocarbons",[],0,{"unitPrice":110,"pack":21,"currency":111,"origin":21,"originFlag":21,"moq":21,"stock":112},9007199254740991,"USD","made-to-order",{"slug":114,"cid":115,"imgSvg":116,"name":117,"nameZh":118,"cas":119,"formula":120,"iupac":117,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":121,"offersCount":69,"supplierCount":25,"bestOffer":122},"785871842446413824","J-1960944-3","\u002Fimages\u002Fchem_structures_svg\u002F495\u002F10534-86-8.svg","Hexaamminecobalt(III) nitrate","六氨合钴(III)硝酸盐","10534-86-8","CoH18N9O9",[23],{"unitPrice":71,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},{"slug":124,"cid":125,"imgSvg":126,"name":127,"nameZh":128,"cas":129,"formula":130,"iupac":127,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":131,"offersCount":24,"supplierCount":25,"bestOffer":132},"785871842576437248","J-814544-6","\u002Fimages\u002Fchem_structures_svg\u002F221\u002F12037-42-2.svg","vanadium oxide","氧化钒","12037-42-2","O13V6",[23],{"unitPrice":133,"pack":134,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},112.8,"100g",{"slug":136,"cid":137,"imgSvg":138,"name":139,"nameZh":140,"cas":141,"formula":142,"iupac":139,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":143,"offersCount":57,"supplierCount":5,"bestOffer":144},"785871842647740416","J-1333345-2","\u002Fimages\u002Fchem_structures_svg\u002F479\u002F26490-63-1.svg","COBALT TETRAFLUOROBORATE HEXAHYDRATE","四氟化硼钴水合物","26490-63-1","B2CoF8H12O6",[23],{"unitPrice":145,"pack":134,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},12,{"slug":147,"cid":148,"imgSvg":149,"name":150,"nameZh":151,"cas":152,"formula":153,"iupac":150,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":154,"offersCount":155,"supplierCount":94,"bestOffer":156},"785871842698072064","J-814953-0","\u002Fimages\u002Fchem_structures_svg\u002F432\u002F72259-10-0.svg","Copper(II) tetrafluoroborate hexahydrate","六水合四氟硼酸铜(II)","72259-10-0","B2CuF8H12O6",[23],10,{"unitPrice":157,"pack":28,"currency":29,"origin":21,"originFlag":21,"moq":21,"stock":32},2.6,{"slug":159,"cid":160,"imgSvg":161,"name":162,"nameZh":163,"cas":164,"formula":165,"iupac":162,"category":53,"categoryName":54,"categoryEnName":55,"industry":21,"tags":166,"offersCount":25,"supplierCount":5,"bestOffer":168},"785871863254355968","J-1990080-7","\u002Fimages\u002Fchem_structures_svg\u002F149\u002F123333-60-8.svg","Cerium(IV) sulfate hydrate","铈(IV)硫酸盐水合物","123333-60-8","CeH2O9S2",[167],"Made to Order",{"unitPrice":169,"pack":28,"currency":29,"origin":30,"originFlag":31,"moq":21,"stock":32},5.6,3204,{"slug":172,"cid":173,"imgSvg":174,"name":175,"nameZh":175,"cas":176,"formula":177,"iupac":175,"mdl":21,"mw":178,"category":179,"categoryName":180,"categoryEnName":181,"industry":21,"tags":182,"synonyms":183,"properties":191,"ghs":254,"offers":255,"activity":256,"upstream":281,"downstream":330,"customs":337,"safetyRows":350,"synthesis":373,"msds":374,"updatedAt":375,"isProhibited":376,"related":377,"__ts":414,"__lang":415,"__slug":173},"785882276901687296","J-2827-9","\u002Fimages\u002Fchem_structures_svg\u002F477\u002F129618-40-2.svg","奈韦拉平","129618-40-2","C15H14N4O","266.298","organic","有机化合物","Organic Compounds",[],[184,185,186,187,188,189,190],"11-环丙基-4-甲基-5,11-二氢-6H-二吡啶并[2,3-e:3',2'-b][1,4]二氮杂卓-6-酮","11-环丙基-4-甲基-5,11-二氢-6H-二吡啶并[3,2-b:2',3'-e][1,4]二氮杂卓-6-酮","11-环丙基-5,11-二氢-4-甲基-6H-二吡啶并(3,2-b:2',3'-e)(1,4)二氮杂卓-6-酮","11-环丙基-5,11-二氢-4-甲基-6H-二吡啶并[3,2-b:2',3'-e][1,4]二氮杂卓-6-酮","6H-二吡啶并(3,2-b:2',3'-e)(1,4)二氮杂卓","奈伟拉平","那伟拉平",[192,197,202,207,212,216,220,223,227,231,235,239,243,247,251],{"label":193,"labelZh":194,"value":195,"prop":196},"Melting Point","熔点","247°C","meltingPoint",{"label":198,"labelZh":199,"value":200,"prop":201},"Boiling Point","沸点","415.4±45.0 °C at 760 mmHg","boilingPoint",{"label":203,"labelZh":204,"value":205,"prop":206},"Density","密度","1.4±0.1 g\u002Fcm3","density",{"label":208,"labelZh":209,"value":210,"prop":211},"Flash Point","闪点","205.0±28.7 °C","flashPoint",{"label":213,"labelZh":214,"value":215},"Exact Mass","精确质量","266.116760",{"label":217,"labelZh":218,"value":219},"PSA","其他信息","63.57000",{"label":221,"labelZh":221,"value":222},"LogP","2.03",{"label":224,"labelZh":225,"value":226},"Appearance","外观性状","固体;White to Light yellow powder to crystal",{"label":228,"labelZh":229,"value":230},"Vapor Pressure","蒸汽压","0.0±1.0 mmHg at 25°C",{"label":232,"labelZh":233,"value":234},"Refractive Index","折射率","1.672",{"label":236,"labelZh":237,"value":238},"Storage Conditions","储存条件","-20°C Freezer",{"label":240,"labelZh":241,"value":242},"Stability","稳定性","pKa2.8。亲油性；分配系数83。水中溶解度：约0.1mg\u002Fml(PH值中性)；在PH\u003C3时易溶。",{"label":244,"labelZh":245,"value":246},"Additional Property","水溶解性","水溶性：不溶；水溶解度：\u003C 0.1 g\u002Fl",{"label":248,"labelZh":249,"value":250},"Computational Chemistry","计算化学","1.疏水参数计算参考值（XlogP）:2\n2.氢键供体数量:1\n3.氢键受体数量:4\n4.可旋转化学键数量:1\n5.互变异构体数量:2\n6.拓扑分子极性表面积58.1\n7.重原子数量:20\n8.表面电荷:0\n9.复杂度:397\n10.同位素原子数量:0\n11.确定原子立构中心数量:0\n12.不确定原子立构中心数量:0\n13.确定化学键立构中心数量:0\n14.不确定化学键立构中心数量:0\n15.共价键单元数量:1",{"label":244,"labelZh":252,"value":253},"更多","1.性状：结晶体\n2.熔点（ºC）：247～249",null,[],[257,260,263,266,269,272,275,278],{"key":258,"value":259},"描述","Nevirapine是用于治疗和预防HIV\u002FAIDS的HIV-1逆转录酶非核苷抑制剂,Ki值为270 μM。",{"key":261,"value":262},"相关类别","信号通路\n>>\n抗感染\n>>\nHIV\n信号通路\n>>\n抗感染\n>>\n逆转录酶\n研究领域\n>>\n感染",{"key":264,"value":265},"靶点","Ki: 270 μM (HIV-1 reverse transcriptase)[1]",{"key":267,"value":268},"体外研究","奈韦拉平本身仅是CYP3A4的抑制剂,其浓度远高于治疗相关性(Ki =270μM)[1]。奈韦拉平已被用作再分化剂,用于治疗几种人类癌症模型中的癌症。在所有测试的剂量(100,200,350,500μM)下,奈韦拉平在48小时处理后显着抑制细胞增殖。在高剂量(500μM)下,与对照相比,奈韦拉平显着增加凋亡细胞的百分比[2]。在几种细胞试验中,奈韦拉平是一种有效的选择性抑制剂(IC50 = 10-100 nM),可以复制多种HIV-1菌株[3]。",{"key":270,"value":271},"体内研究","奈韦拉平可与核苷HIV-1逆转录酶抑制剂(例如,齐多夫定,去羟肌苷等)组合使用。奈韦拉平已获得FDA批准与HIV-1蛋白酶抑制剂(如沙奎那韦,利托那韦,茚地那韦等)联合使用。在人类中,奈韦拉平主要在尿液中作为2-,3-,8-和12-羟基奈韦拉平的葡糖苷酸结合物被消除[1]。奈韦拉平完全被小鼠,大鼠,兔子,猴子和黑猩猩的性别所吸收。奈韦拉平在研究的所有动物物种的两性中都有广泛代谢[4]。与对照组相比,奈韦拉平(9 mg\u002Fkg,18 mg\u002Fkg和36 mg\u002Fkg)显示溃疡严重程度评分和溃疡指数显着降低[5]",{"key":273,"value":274},"细胞实验","将FRO细胞以10,000个细胞\u002F孔接种到96孔培养板中。用不同剂量的奈韦拉平（0,100,200,350和500μM）处理细胞48小时。将MTT染料（5mg \u002F mL）加入各孔中另外4小时，然后通过加入DMSO终止反应。在多孔板读数器上测量490nm处的光密度[2]。",{"key":276,"value":277},"动物实验","大鼠：将奈韦拉平和[14 C]奈韦拉平在无水乙醇和二氯甲烷（1：1，v \u002F v）中一起溶解，同时温和加热。对于大鼠口服给药，悬浮液中的药物浓度为2mg \u002F mL（20mg \u002F kg，26μCi），对于大鼠十二指肠内给药，为6.7mg \u002F mL（20.3mg \u002F kg，10μCi雄性，8.9μCi雌性）。胆汁收集。静脉注射给大鼠（1.1mg \u002F kg，20μCi），为20％乙醇\u002F 80％盐水溶液[4]。小鼠：奈韦拉平和[14 C]奈韦拉平在无水乙醇和二氯甲烷（1：1，v \u002F v）中一起溶解，同时温和加热。悬浮液中的药物浓度为2 mg \u002F mL（20 mg \u002F kg，2.5μCi），对小鼠口服给药的比活性为5.55μCi\u002F mg [4]。",{"key":279,"value":280},"参考文献","[1].\nErickson DA, et al. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitornevirapine by human hepatic cytochromes P-450. Drug Metab Dispos. 1999 Dec;27(12):1488-95.\n[2].\nDong JJ, et al. In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma. Mol Cell Endocrinol. 2013 May 6;370(1-2):113-8.\n[3].\nMerluzzi VJ, et al. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science. 1990 Dec 7;250(4986):1411-3.\n[4].\nRiska PS, et al. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Drug Metab Dispos. 1999 Dec;27(12):1434-47.\n[5].\nOnasanwo SA, et al. Evaluation of anti-ulcerogenic and ulcer-healing activities of nevirapine in rats. Afr J Med Med Sci. 2015 Sep;44(3):251-9.",[282,288,294,300,306,312,318,324],{"slug":283,"cid":284,"name":285,"nameZh":285,"cas":286,"imgSvg":287},"785883276521771000","J-881874-6","N-(2-氯-4-甲基-3-吡...","133627-47-1","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F414\u002F133627-47-1.svg",{"slug":289,"cid":290,"name":291,"nameZh":291,"cas":292,"imgSvg":293},"785882276578725900","J-1135215-8","2-氯-N-(2-氯-4-甲基...","133627-46-0","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F452\u002F133627-46-0.svg",{"slug":295,"cid":296,"name":297,"nameZh":297,"cas":298,"imgSvg":299},"785896443280887800","J-1062223-6","环丙胺","765-30-0","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F495\u002F765-30-0.svg",{"slug":301,"cid":302,"name":303,"nameZh":303,"cas":304,"imgSvg":305},"785883157625835500","J-7303-3","2-氯-4-甲基-3-硝基吡啶","23056-39-5","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F403\u002F23056-39-5.svg",{"slug":307,"cid":308,"name":309,"nameZh":309,"cas":310,"imgSvg":311},"785892562656301000","J-32906-0","甲基叔丁基醚","1634-04-4","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F266\u002F1634-04-4.svg",{"slug":313,"cid":314,"name":315,"nameZh":315,"cas":316,"imgSvg":317},"785893516638163000","J-1497850-4","2-氯-3-吡啶羧酸","49609-84-9","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F123\u002F49609-84-9.svg",{"slug":319,"cid":320,"name":321,"nameZh":321,"cas":322,"imgSvg":323},"785882276121546800","J-2821-3","2-氯-3-氨基-4-甲基吡啶","133627-45-9","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F000\u002F133627-45-9.svg",{"slug":325,"cid":326,"name":327,"nameZh":327,"cas":328,"imgSvg":329},"785882271742693400","J-2785-2","2-氯烟酸","2942-59-8","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F155\u002F2942-59-8.svg",[331],{"slug":332,"cid":333,"name":334,"nameZh":334,"cas":335,"imgSvg":336},"785889953027461100","J-1392158-9","2-环丙基氨基烟酸","639807-18-4","https:\u002F\u002Fapi.chemical.xiaokangmed.com\u002Fimages\u002Fchem_structures_svg\u002F424\u002F639807-18-4.svg",[338,341,344,347],{"key":339,"value":340},"海关编码","2934994000",{"key":342,"value":343},"中文概述","2934994000. 奈韦拉平、依发韦仑、利托那韦及它们的盐. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最低关税:6.5%. 普通关税:20.0%",{"key":345,"value":346},"申报要素","品名, 成分含量, 用途",{"key":348,"value":349},"Summary","2934994000. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%",[351,354,357,360,363,366,369,372],{"key":352,"value":353},"危害码 (欧洲)","Xi: Irritant;",{"key":355,"value":356},"风险声明 (欧洲)","R36\u002F37\u002F38",{"key":358,"value":359},"安全声明 (欧洲)","S26-S36-S36\u002F37",{"key":361,"value":362},"危险品运输编码","UN 2206 6.1\u002FPG 3",{"key":364,"value":365},"WGK德国","3",{"key":367,"value":368},"包装等级","III",{"key":370,"value":371},"危险类别","6.1",{"key":339,"value":340},"\u003Cp>2-羟基-4-甲基--3-硝基吡啶经三氯氧磷氯化，得到的化合物经还原得到3-氨基-2-氯-4-甲基吡啶。用2-氯烟酰氯对该物质进行酰胺化，再和环丙胺缩合得化合物，最后在二甲基甲酰胺中回流，得到奈韦拉平。\u003C\u002Fp>\u003Cp>\u003C\u002Fp>\u003Cp>\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\u003C\u002Fp>","\u003Ctd>\n\n\n\u003Cstrong>模块1. 化学品\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>1.1 产品标识符\u003C\u002Fb>\n\u003Cbr \u002F> : Nevirapine\n\u003Cbr \u002F> 产品名称\n\u003Cbr \u002F>\n\u003Cb>1.2 鉴别的其他方法\u003C\u002Fb>\n\u003Cbr \u002F> BI-RG 587\n\u003Cbr \u002F> NSC 641530\n\u003Cbr \u002F> NVP\n\u003Cbr \u002F> Nevarapine\n\u003Cbr \u002F> Navirapi\n\u003Cbr \u002F>\n\u003Cb>1.3 有关的确定了的物质或混合物的用途和建议不适合的用途\u003C\u002Fb>\n\u003Cbr \u002F> 仅用于研发。不作为药品、家庭或其它用途。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块2. 危险性概述\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>2.1 GHS-分类\u003C\u002Fb>\n\u003Cbr \u002F> 非危险物质或混合物。\n\u003Cbr \u002F>\n\u003Cb>2.3 其它危害物 - 无\u003C\u002Fb>\n\u003Cbr \u002F>\n\n\u003Cstrong>模块3. 成分\u002F组成信息\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>3.1 物 质\u003C\u002Fb>\n\u003Cbr \u002F> : BI-RG 587\n\u003Cbr \u002F> 别名\n\u003Cbr \u002F> NSC 641530\n\u003Cbr \u002F> NVP\n\u003Cbr \u002F> Nevarapine\n\u003Cbr \u002F> Navirapi\n\u003Cbr \u002F> : C15H14N4O\n\u003Cbr \u002F> 分子式\n\u003Cbr \u002F> : 266.30 g\u002Fmol\n\u003Cbr \u002F> 分子量\n\u003Cbr \u002F> 无\n\u003Cbr \u002F>\n\n\u003Cstrong>模块4. 急救措施\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>4.1 必要的急救措施描述\u003C\u002Fb>\n\u003Cbr \u002F> 吸入\n\u003Cbr \u002F> 如果吸入,请将患者移到新鲜空气处。 如呼吸停止,进行人工呼吸。\n\u003Cbr \u002F> 皮肤接触\n\u003Cbr \u002F> 用肥皂和大量的水冲洗。\n\u003Cbr \u002F> 眼睛接触\n\u003Cbr \u002F> 用水冲洗眼睛作为预防措施。\n\u003Cbr \u002F> 食入\n\u003Cbr \u002F> 切勿给失去知觉者通过口喂任何东西。 用水漱口。\n\u003Cbr \u002F>\n\u003Cb>4.2 主要症状和影响，急性和迟发效应\u003C\u002Fb>\n\u003Cbr \u002F> 据我们所知，此化学，物理和毒性性质尚未经完整的研究。\n\u003Cbr \u002F>\n\u003Cb>4.3 及时的医疗处理和所需的特殊处理的说明和指示\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块5. 消防措施\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>5.1 灭火介质\u003C\u002Fb>\n\u003Cbr \u002F> 灭火方法及灭火剂\n\u003Cbr \u002F> 用水雾,抗乙醇泡沫,干粉或二氧化碳灭火。\n\u003Cbr \u002F>\n\u003Cb>5.2 源于此物质或混合物的特别的危害\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>5.3 给消防员的建议\u003C\u002Fb>\n\u003Cbr \u002F> 如必要的话,戴自给式呼吸器去救火。\n\u003Cbr \u002F>\n\u003Cb>5.4 进一步信息\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块6. 泄露应急处理\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>6.1 作业人员防护措施、防护装备和应急处置程序\u003C\u002Fb>\n\u003Cbr \u002F> 避免粉尘生成。 避免吸入蒸气、烟雾或气体。\n\u003Cbr \u002F>\n\u003Cb>6.2 环境保护措施\u003C\u002Fb>\n\u003Cbr \u002F> 不要让产品进入下水道。\n\u003Cbr \u002F>\n\u003Cb>6.3 泄漏化学品的收容、清除方法及所使用的处置材料\u003C\u002Fb>\n\u003Cbr \u002F> 扫掉和铲掉。 放入合适的封闭的容器中待处理。\n\u003Cbr \u002F>\n\u003Cb>6.4 参考其他部分\u003C\u002Fb>\n\u003Cbr \u002F> 丢弃处理请参阅第13节。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块7. 操作处置与储存\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>7.1 安全操作的注意事项\u003C\u002Fb>\n\u003Cbr \u002F> 在有粉尘生成的地方,提供合适的排风设备。\n\u003Cbr \u002F>\n\u003Cb>7.2 安全储存的条件,包括任何不兼容性\u003C\u002Fb>\n\u003Cbr \u002F> 贮存在阴凉处。 使容器保持密闭，储存在干燥通风处。\n\u003Cbr \u002F>\n\u003Cb>7.3 特定用途\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块8. 接触控制和个体防护\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>8.1 容许浓度\u003C\u002Fb>\n\u003Cbr \u002F> 最高容许浓度\n\u003Cbr \u002F> 没有已知的国家规定的暴露极限。\n\u003Cbr \u002F>\n\u003Cb>8.2 暴露控制\u003C\u002Fb>\n\u003Cbr \u002F> 适当的技术控制\n\u003Cbr \u002F> 常规的工业卫生操作。\n\u003Cbr \u002F> 个体防护设备\n\u003Cbr \u002F> 眼\u002F面保护\n\u003Cbr \u002F> 请使用经官方标准如NIOSH (美国) 或 EN 166(欧盟) 检测与批准的设备防护眼部。\n\u003Cbr \u002F> 皮肤保护\n\u003Cbr \u002F> 戴手套取 手套在使用前必须受检查。\n\u003Cbr \u002F> 请使用合适的方法脱除手套(不要接触手套外部表面),避免任何皮肤部位接触此产品.\n\u003Cbr \u002F> 使用后请将被污染过的手套根据相关法律法规和有效的实验室规章程序谨慎处理. 请清洗并吹干双手\n\u003Cbr \u002F> 所选择的保护手套必须符合EU的89\u002F686\u002FEEC规定和从它衍生出来的EN 376标准。\n\u003Cbr \u002F> 身体保护\n\u003Cbr \u002F> 根据危险物质的类型，浓度和量，以及特定的工作场所选择身体保护措施。,\n\u003Cbr \u002F> 防护设备的类型必须根据特定工作场所中的危险物的浓度和数量来选择。\n\u003Cbr \u002F> 呼吸系统防护\n\u003Cbr \u002F> 不需要保护呼吸。如需防护粉尘损害，请使用N95型（US）或P1型（EN 143)防尘面具。\n\u003Cbr \u002F> 呼吸器使用经过测试并通过政府标准如NIOSH（US）或CEN（EU）的呼吸器和零件。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块9. 理化特性\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>9.1 基本的理化特性的信息\u003C\u002Fb>\n\u003Cbr \u002F> a) 外观与性状\n\u003Cbr \u002F> 形状: 固体\n\u003Cbr \u002F> b) 气味\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> c) 气味阈值\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> d) pH值\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> e) 熔点\u002F凝固点\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> f) 沸点、初沸点和沸程\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> g) 闪点\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> h) 蒸发速率\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> i) 易燃性(固体,气体)\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> j) 高的\u002F低的燃烧性或爆炸性限度 无数据资料\n\u003Cbr \u002F> k) 蒸气压\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> l) 蒸汽密度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> m) 密度\u002F相对密度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> n) 水溶性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> o) n-辛醇\u002F水分配系数\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> p) 自燃温度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> q) 分解温度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> r) 粘度\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块10. 稳定性和反应活性\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>10.1 反应性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.2 稳定性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.3 危险反应\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.4 应避免的条件\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>10.5 不相容的物质\u003C\u002Fb>\n\u003Cbr \u002F> 强氧化剂\n\u003Cbr \u002F>\n\u003Cb>10.6 危险的分解产物\u003C\u002Fb>\n\u003Cbr \u002F> 其它分解产物 - 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块11. 毒理学资料\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>11.1 毒理学影响的信息\u003C\u002Fb>\n\u003Cbr \u002F> 急性毒性\n\u003Cbr \u002F> 最低致死剂量 经口 - 大鼠 - 400 mg\u002Fkg\n\u003Cbr \u002F> 最低致死剂量 经口 - 犬 - 3,200 mg\u002Fkg\n\u003Cbr \u002F> TDLo 腹膜内的 - 大鼠 - 150 mg\u002Fkg\n\u003Cbr \u002F> 皮肤刺激或腐蚀\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 眼睛刺激或腐蚀\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 呼吸道或皮肤过敏\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 生殖细胞致突变性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 致癌性\n\u003Cbr \u002F> IARC:\n\u003Cbr \u002F> 此产品中没有大于或等于 0。1%含量的组分被 IARC鉴别为可能的或肯定的人类致癌物。\n\u003Cbr \u002F> 生殖毒性\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 特异性靶器官系统毒性（一次接触）\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 特异性靶器官系统毒性（反复接触）\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 吸入危险\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F> 潜在的健康影响\n\u003Cbr \u002F> 吸入吸入可能有害。 可能引起呼吸道刺激。\n\u003Cbr \u002F> 摄入如服入是有害的。\n\u003Cbr \u002F> 皮肤通过皮肤吸收可能有害。 可能引起皮肤刺激。\n\u003Cbr \u002F> 眼睛可能引起眼睛刺激。\n\u003Cbr \u002F> 接触后的征兆和症状\n\u003Cbr \u002F> 据我们所知，此化学，物理和毒性性质尚未经完整的研究。\n\u003Cbr \u002F> 附加说明\n\u003Cbr \u002F> 化学物质毒性作用登记: 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块12. 生态学资料\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>12.1 生态毒性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.2 持久性和降解性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.3 潜在的生物累积性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.4 土壤中的迁移性\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.5 PBT 和 vPvB的结果评价\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\u003Cb>12.6 其它不良影响\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块13. 废弃处置\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>13.1 废物处理方法\u003C\u002Fb>\n\u003Cbr \u002F> 产品\n\u003Cbr \u002F> 将剩余的和不可回收的溶液交给有许可证的公司处理。\n\u003Cbr \u002F> 受污染的容器和包装\n\u003Cbr \u002F> 按未用产品处置。\n\u003Cbr \u002F>\n\n\u003Cstrong>模块14. 运输信息\u003C\u002Fstrong>\n\u003Cbr \u002F>\n\u003Cb>14.1 联合国危险货物编号\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.2 联合国运输名称\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: 非危险货物\n\u003Cbr \u002F> 国际海运危规: 非危险货物\n\u003Cbr \u002F> 国际空运危规: 非危险货物\n\u003Cbr \u002F>\n\u003Cb>14.3 运输危险类别\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.4 包裹组\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: -国际海运危规: -\n\u003Cbr \u002F>\n\u003Cb>14.5 环境危险\u003C\u002Fb>\n\u003Cbr \u002F> 欧洲陆运危规: 否国际海运危规\n\u003Cbr \u002F> 海洋污染物（是\u002F否）: 否\n\u003Cbr \u002F>\n\u003Cb>14.6 对使用者的特别提醒\u003C\u002Fb>\n\u003Cbr \u002F> 无数据资料\n\u003Cbr \u002F>\n\n\u003Cstrong>模块16. 其他信息\u003C\u002Fstrong>\n\u003Cbr \u002F> 进一步信息\n\u003Cbr \u002F> 版权所有：2013 Co. LLC. 公司。许可无限制纸张拷贝，仅限于内部使用。\n\u003Cbr \u002F> 上述信息视为正确，但不包含所有的信息，仅作为指引使用。本文件中的信息是基于我们目前所知，就正\n\u003Cbr \u002F> 确的安全提示来说适用于本品。该信息不代表对此产品性质的保证。\n\u003Cbr \u002F> 参见发票或包装条的反面。\n\u003Cbr \u002F>\n\u003Cbr \u002F>\n\n\u003Cstrong> 模块 15 - 法规信息 \u003C\u002Fstrong>\n\u003Cbr \u002F>N\u002FA\n\u003Cbr \u002F>\n\u003Cbr \u002F>\u003Cbr \u002F>\u003Cbr \u002F>\n\u003C\u002Ftd>","2026-08-21T07:51:12.859463Z",false,[378,384,390,396,402,408],{"slug":379,"cid":380,"name":381,"nameZh":382,"cas":383},"785895059647107072","J-39988-7","Maneb","代森锰","12427-38-2",{"slug":385,"cid":386,"name":387,"nameZh":388,"cas":389},"785897759302488064","J-47789-5","Potassium 5-mercapto-3-phenyl-1,3,4-thiadiazole-2-thione","铋试剂II","6336-51-2",{"slug":391,"cid":392,"name":393,"nameZh":394,"cas":395},"785896201537982464","J-1513803-1","5-(4-Dimethylaminobenzylidene)rhodanine","对二甲氨基苄罗丹宁","536-17-4",{"slug":397,"cid":398,"name":399,"nameZh":400,"cas":401},"785882575020232704","J-4798-8","m-Methyl red","间甲基红","20691-84-3",{"slug":403,"cid":404,"name":405,"nameZh":406,"cas":407},"785894611636719616","J-38269-8","Methyl Red","甲基红","493-52-7",{"slug":409,"cid":410,"name":411,"nameZh":412,"cas":413},"785881280762875904","J-18554-3","Sodium carboxymethyl cellulose","羧甲基纤维素钠","9004-32-4",1792646117110,"zh-CN",[]]